Vaccine Adjuvants Market to Worth US$ 1,617.3 Million by 2027 | Industry CAGR of 12.82%

IMARC Group has recently released a new research study titled "Vaccine Adjuvants Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027", This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the market in any form.

What are the growth prospects of the vaccine adjuvants industry?

The global vaccine adjuvants market size reached US$ 773.6 Million in 2021. Looking forward, IMARC Group expects the market to reach US$ 1,617.3 Million by 2027, exhibiting a growth rate (CAGR) of 12.82% during 2022-2027.

What is a vaccine adjuvants?

Vaccine adjuvants are compounds utilized for improving the biological activity and the immunogenicity of a pharmaceutical preparation intended for the immunization of humans and animals against numerous diseases. They can be administered in oral, intramuscular, intranasal, subcutaneous, and intradermal forms. They aid in improving the response of the body to vaccination, minimizing the number of vaccine doses given to patients, and reducing the amount of injected foreign material. They rely on aluminum salts, such as aluminum hydroxide, aluminum phosphate, and aluminum potassium sulfate, to protect against diseases and provide more prolonged effectiveness. They are widely used in hepatitis A, hepatitis B, diphtheria-tetanus, Haemophilus influenzae type B, and pneumococcal vaccines.

Impact of COVID-19:

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Get a PDF Sample for more detailed market insights: https://www.imarcgroup.com/vaccine-adjuvants-market/requestsample

What are the major market drivers in the vaccine adjuvants market?

The increasing prevalence of contagious infections, such as human immunodeficiency virus (HIV), acquired immune deficiency syndrome (AIDS), and human papillomavirus (HPV), represents one of the major factors positively influencing the demand for vaccine adjuvants around the world. The rising occurrence of cancer among the masses, especially the geriatric population, which is more susceptible to such medical conditions, is also strengthening the market growth. It can also be accredited to the growing consumption of alcohol and tobacco products on account of sedentary lifestyles and high-stress levels. In addition, increasing incidences of zoonotic diseases, including animal flu and tick infestation, are favoring the market growth. It can also be attributed to the emerging trend of adopting pets for companionship and consequently increasing spread of animal-borne diseases. The rising awareness about animal health is also driving the demand for vaccine adjuvants worldwide. Apart from this, the increasing number of airborne diseases on account of the growing air pollution levels is resulting in the rising utilization of vaccine adjuvants. Along with this, the growing demand for effective and safe vaccine adjuvants is creating a positive outlook for the market. Moreover, the expanding number of clinical trials by pharmaceutical companies to improve vaccines that offer long-lasting effects on immunization is contributing to the market growth. Furthermore, governments of several countries are undertaking initiatives to monitor the distribution, supply, and administration of vaccine adjuvants, which is providing a thrust to the market growth. Besides this, due to inflating income levels, there is a rise in demand for sophisticated treatment options to minimize the risk of developing allergies. Additionally, continual technological advancements in the vaccine production process, significant improvement in the healthcare infrastructure, and extensive research and development (R&D) activities in the field of biotechnology are anticipated to propel the market growth in the coming years.

Vaccine Adjuvants Market 2022-2027 Competitive Analysis and Segmentation:

The report has segmented the market based on product type, route of administration, diseases and application.

Breakup by Product Type:
Adjuvant Emulsions
Pathogen Components
Particulate Adjuvants
Combination Adjuvants
Others

Breakup by Route of Administration:
Oral
Intramuscular
Intranasal
Subcutaneous
Intradermal
Others

Breakup by Diseases:
Cancer
Infectious Diseases
Others

Breakup by Application:
Research
Commercial

Breakup by Region:
North America
Asia-Pacific
Europe
Latin America
Middle East and Africa

List of Major Key Players:

The major players in the market are

Adjuvance Tecchnologies Inc.
Adjuvatis
Agenus Inc.
Brenntag SE
Chemtrade Logistics Inc.
CSL Limited
Croda International Plc
Invivogen
Novavax Inc.
OZ Biosciences
Virometix AG.

Key Highlights of the Report:
Market Performance (2016-2021)
Market Outlook (2022-2027)
Market Trends
Market Drivers and Success Factors
Impact of COVID-19
Value Chain Analysis
Comprehensive mapping of the competitive landscape

Ask Customization and Browse full report with TOC & List of Figure: https://www.imarcgroup.com/vaccine-adjuvants-market

If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

Top Trending Reports (Book Now with 10% Discount + COVID-19 Scenario):

Security Testing Market- https://www.openpr.com/news/2633067/security-testing-market-2021-2026-industry-trends-share

Smart Stadium Market- https://www.openpr.com/news/2633091/smart-stadium-market-2021-2026-share-size-demand-industry

Managed Print Services Market- https://www.openpr.com/news/2633110/managed-print-services-market-share-size-demand-industry

Alopecia Treatment Market- https://www.openpr.com/news/2633153/alopecia-treatment-market-2022-2027-share-size-growth

Precast Concrete Market- https://www.openpr.com/news/2633174/precast-concrete-market-report-2022-2027-industry-analysis

Business Process-As-A-Service (BPaaS) Market- https://www.openpr.com/news/2633191/business-process-as-a-service-bpaas-market-2022-2027

Social Robots Market- https://www.openpr.com/news/2633212/social-robots-market-report-2022-2027-size-share-growth

Contact us:

IMARC Group
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Website: https://www.imarcgroup.com
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas: - +1 631 791 1145 | Africa and Europe: - +44-702-409-7331 | Asia: +91-120-433-0800

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.